Rating Change
JP Morgan reiterated its Neutral rating on Progyny, Inc. (NASDAQ:PGNY) on November 09, 2026.
JP Morgan reiterated its Neutral rating on Progyny, Inc. (NASDAQ:PGNY) on November 09, 2026.

At publication ·
Progyny, Inc. (NASDAQ:PGNY) · reiterate
At a glance
JP Morgan reiterated its Neutral rating on Progyny, Inc. (NASDAQ:PGNY) on November 09, 2026.
Progyny, Inc. operates in the Healthcare sector. The stock currently trades at $35.95 with a market capitalization of $2.2B.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Progyny, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 09, 2026 | JP Morgan | Neutral | N/A |
| Nov 05, 2026 | Wells Fargo | Overweight | N/A |
| Nov 05, 2026 | Leerink Partners | Outperform | N/A |
| Nov 05, 2026 | Citizens | Market Outperform | N/A |
| Nov 05, 2026 | Cantor Fitzgerald | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View PGNY Stock Page
A rating of Neutral from JP Morgan reflects the analyst's outlook on Progyny, Inc. (NASDAQ:PGNY). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PGNY forecast page.
Current market data
NASDAQ · PGNY
$36.50
Up: +$0.07 · +0.19%
Live quote updated
Keep reading
analyst ·
analyst ·
analyst ·
analyst ·